Original Articles
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 15, 2000; 6(5): 693-698
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.693
Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma
Xiao Feng Huang, Chun Mei Wang, Xiao Wen Dai, Zhen Jiang Li, Bo Rong Pan, Li Bin Yu, Bin Qian, Li Fang
Xiao Feng Huang, Chun Mei Wang, Department of Electron Microscopy, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China
Xiao Wen Dai, Zhen Jiang Li, Li Bin Yu, Bin Qian, Li Fang, Department of Pathology, Chinese PLA 117 Hospital, Hangzhou 310013, Zhejiang Province, China
Bo Rong Pan, Room 12, Building 621, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China
Xiao Feng Huang, earned Ph.D from the Fourth Military Medical University in 1997, now working in the Department of Electron Microscopy, Fourth Military Medical University, having 52 papers published.
Author contributions: All authors contributed equally to the work.
Supported by the Foundation of Chinese PLA 117 Hospital, No.98009
Correspondence to: Xiao Feng Huang, Department of Electron Microscopy, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China. fmmuem@fmmu.edu.cn
Telephone: 0086-29-3374572
Received: May 6, 2000
Revised: May 25, 2000
Accepted: June 2, 2000
Published online: October 15, 2000
Abstract

AIM: To determine the expression and clinical significance of chromogranin A and cathepsin D in hepatocellular carcinoma (HCC).

METHODS: Double immunofluorescence staining techniques combined with laser confocal scanning microscopy (LSCM) was used to investigate chromogranin A and cathepsin D expressions in 85 HCC patients.

RESULTS: Cathepsin D was expressed in 3 normal liver tissues, while in HCC the staining showed regional variation and the fraction of strongly stained cells increased as the tumors became less differentiated and usually clinically more malignant. Cells which showed strong positivity for cathepsin D were present in 71/85 (83.5%) cases. Strong expression of cathepsin D in cancer cells was related to histopathological features. They were more common in grade 3-4 (26/28, 92.9%) and grade 2 (46/53, 86.8%) tumors than in grade 1 tumors (1/4, 25.0%) (P < 0.01). No significant correlation was found between age and cathepsin D expression. In patients with positive cathepsin D reaction, the mean age was 52.1 ± 2.8 years (range 32-68 years) and in the group with negative reaction, the mean age was 51.3 ± 4.5 years (range 28-71 years). No obvious relationship was observed between CgA expression in cancer cells and the histopathological features. The CgA positive rate was 75.0% (3/4) in grade 1, 71.7% (38/53) in grade 2, and 71.4% (20/28) in grade 3-4 (P > 0.05) tumors. The coexpression of CgA and cathepsin D was found by double labeled immunofluorescence staining techniques. The processing of cathepsin D was disturbed in HCC cells and accumulated in the cells. Cathepsin D had proteolytic activity and autocrine mitogenic effect, suggesting their functions in invasion. These findings demonst rated that the expression of cathepsin D in HCC had prognostic value.

CONCLUSION: Chromogranin A and cathepsin D are expressed in a high proportion of HCC and the existence of cathepsin D in HCC might be related to processing of CgA. This is clearly a subject for further studies because of its potential clinical applications.

Keywords: carcinoma, hepatocellular/pathology; cathepsin D/metabolism; chromogranins/metabolism; microscopy, confocal